Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:2058-2059
Published online before print September 22, 2005, doi: 10.1161/01.STR.0000185931.20915.6f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/10/2058    most recent
01.STR.0000185931.20915.6fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kent, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kent, D. M.
Related Collections
Right arrowRelated Article

(Stroke. 2005;36:2058.)
© 2005 American Heart Association, Inc.


Editorials

Improved Perioperative Outcomes From Carotid Endarterectomy

Yet Another Statin Side Effect?

David M. Kent, MD, MS

From the Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, Boston, Mass.

Correspondence to David M. Kent, MD, MS, Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, 750 Washington St, Box 63, Boston, MA 02138. E-mail dkent1@tufts-nemc.org


Key Words: carotid endarterectomy • treatment outcome


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

A cardiologist colleague at our hospital jokes that he prefers to prescribe medicines when they are first marketed because they have fewer side effects. As a rule, much remains unknown about the unintended effects of pharmaceutical agents at the time of an initial drug launch, and with some regularity, these side consequences yield black box warnings, product recalls, and even congressional hearings.1 The rule of unintended effects applies also to statins; with each passing month, it seems the literature has several new reports about the unexpected effects of these agents. However, with paradoxical and almost miraculous consistency, the side consequences of statins are health promoting and life prolonging. Through a variety of biochemical pathways, statins exert pleiotropic physiological effects,2,3 in addition to their lipid-lowering effects, which include improving endothelial dysfunction, enhancing atherosclerotic plaque stability, increasing NO bioavailability, decreasing oxidative stress, blunting the inflammatory response, increasing bone mineral density, and inhibiting thrombogenesis. These physiological effects are believed to have potential benefit for a wide variety of disorders, including (but not limited to) preventing Alzheimer disease, slowing progression of chronic kidney disease, treating osteoporosis and rheumatic diseases, preventing type 2 diabetes, preventing prostate and colon cancer, and even reducing mortality in pneumonia and sepsis.4,5 These putative effects are so varied and salubrious that readers (of a certain generation) may think of statins as the pharmaceutical equivalent of "Shimmer," the versatile if fictitious household product from the spoof advertisement on Saturday Night Live: "It’s a floor wax AND a dessert topping!"

In . . . [Full Text of this Article]


Related Article:

Statins Are Associated With Better Outcomes After Carotid Endarterectomy in Symptomatic Patients
James Kennedy, Hude Quan, Alastair M. Buchan, William A. Ghali, and Thomas E. Feasby
Stroke 2005 36: 2072-2076. [Abstract] [Full Text] [PDF]